Splendris Pharmaceuticals GmbH, founded in 2011, is an international company with a professional focus on the healthcare market.
Splendris Pharmaceuticals GmbH is focused in providing medicinal products for human health in the segments of:
- Cardiovascular
- Oncology
- Diabetes
- and Antibiotics
Further information can be found on our website at “products” and “licences“.
Contact us now online: contact form.
Splendris Pharmaceuticals GmbH – History:
- 2012 Marketing Authorisation of Benazepril Tablets approved by national procedure
- 2011 Marketing Authorisation of Clopidogrel Tablets approved by DCP procedure
- 2011 Fundation of Splendris Pharmaceuticals GmbH
